KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Long-Term Investments (2016 - 2025)

Chemed (CHE) has 17 years of Long-Term Investments data on record, last reported at $140.3 million in Q4 2025.

  • For Q4 2025, Long-Term Investments rose 7.17% year-over-year to $140.3 million; the TTM value through Dec 2025 reached $140.3 million, up 7.17%, while the annual FY2025 figure was $140.3 million, 7.17% up from the prior year.
  • Long-Term Investments reached $140.3 million in Q4 2025 per CHE's latest filing, up from $136.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $140.3 million in Q4 2025 and bottomed at $90.1 million in Q3 2022.
  • Average Long-Term Investments over 5 years is $110.5 million, with a median of $103.2 million recorded in 2021.
  • Peak YoY movement for Long-Term Investments: increased 29.61% in 2021, then dropped 11.71% in 2022.
  • A 5-year view of Long-Term Investments shows it stood at $98.9 million in 2021, then decreased by 5.75% to $93.2 million in 2022, then grew by 13.87% to $106.1 million in 2023, then increased by 23.4% to $131.0 million in 2024, then rose by 7.17% to $140.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $140.3 million in Q4 2025, $136.0 million in Q3 2025, and $129.6 million in Q2 2025.